U.S. supply of remdesivir could run out within weeks, top official warns
Washington — The federal government’s supply of remdesivir, an FDA-authorized drug that was found to lessen the recovery time for patients hospitalized with the coronavirus, could be tapped out by the end of June, a top official from the Department of Health and Human Services (HHS) warned.
Dr. Robert Kadlec, the assistant secretary for preparedness and response at the federal health agency, told CNN that the administration’s last shipment of remdesivir, manufactured by Gilead Sciences, will be sent the week of June 29.
“Right now we’re waiting to hear from Gilead what is their expected delivery availability of the drug as we go from June to July,” Kadlec said. “We’re kind of not in negotiations but in discussions with Gilead as they project what the availability of their product will be.”
Kadlec told CNN the federal government has been assisting Gilead “with some of …continued .
[Source: CBS News]